摘要
前哨淋巴结活检（SLNB）是本世纪继早期乳腺癌保乳治疗后第二个最重要的进展，前哨淋巴结活检是种多学科结合的新方法，比腋窝淋巴结清扫更能准确的进行腋窝分期，乳腺癌前哨淋巴结活检很快运用到临床实践。适当选择病人，由有经验的多学科团队进行前哨淋巴结活检，其精确度超过95％，前哨淋巴结活检广泛应用在可触及的和不可触及的T1和T2的肿瘤病人。最近研究表明，前哨淋巴结活检技术可应用在多中心多病灶的和新辅助化疗后和局部晚期乳腺癌病人。前哨淋巴结活检的重要因素包括注射技术，病例选择，病理分析和活检精确度等，为此简要综述如下。
Sentinel lymph node （SLN） biopsy is the second most important development in this century after conservative lumpectomy for the treatment of early breast cancer. The sentinel node biopsy is a new multidisciplinary approach for staging of axilla in an accurate way as compared to axillary node dissection. Sentinel lymph node biopsy in patients with breast cancer has been adopted rapidly into clinical practice. The accuracy of sentinel lymph node biopsy is more than 95%, when performed by an experienced multidisciplinary team with proper patient selection. Sentinel lymph node biopsy is most widely used for both palpable and non-palpable T1 and T2 tumors. Recent studies show the application of sentinel node biopsy technique in patients with locally advanced breast cancer and breast cancer after neoadjuvant chemotherapy and multicentric breast cancer. Important aspects of the sentinel lymph node biopsy inolude injection techniques, case selection, pathologic analysis and its accuracy and so on. Therefore, in this review the new technique will be concisely introduced.
出处
《世界肿瘤杂志》
2007年第2期141-144,共4页
Tumour Journal of the World
基金
广西青年科学基金项目（N0.0339032）
关键词
乳腺癌
前哨淋巴结
活检
Breast cancer
sentinel lymph node
biopsy
